SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001171843-17-002416
Filing Date
2017-04-28
Accepted
2017-04-28 16:15:14
Documents
5
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a_042817.htm DEFA14A 16495
2 GRAPHIC notice_1.jpg GRAPHIC 100153
3 GRAPHIC notice_2.jpg GRAPHIC 171631
4 GRAPHIC notice_3.jpg GRAPHIC 79123
5 GRAPHIC notice_4.jpg GRAPHIC 20086
  Complete submission text file 0001171843-17-002416.txt   500246
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14027 | Film No.: 17795720
SIC: 3841 Surgical & Medical Instruments & Apparatus